Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Novartis-sponsored Phase 2 trial of INC280 (capmatinib) for advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Dendritic Killer Cell-based Immunotherapy for Solid Tumors [Phase 1]
An ongoing Phase 1 clinical trial of a dendritic killer cell–based immunotherapy for solid tumors is described, with colorectal neoplasms an…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Liver Cancer HepaSphere Combined With Cryosurgery [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating HepaSphere drug-eluting beads in combination with cryosurgery for liver cancer. Sponsor: Fud…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Hepatocellular Carcinoma and Rheumatoid Arthritis
Completed clinical trial update involving hepatocellular carcinoma and rheumatoid arthritis sponsored by Taipei Tzu Chi Hospital.
-
CLINICAL_TRIALS research · 2016-08-25Clinical Trial Update: PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach) [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of a PD-1 antibody expressing CAR-T cell therapy targeting EGFR family member positive …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating G-202 (Mipsagargin) as second-line therapy after sorafenib in advanced hepa…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis [Phase 4]
Phase 4 trial update evaluating MRI with gadoxetic acid for non-invasive diagnosis of hepatocellular carcinoma in patients with liver cirrho…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of combining radiotherapy and hyperthermia after transarterial chemoembolization in he…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres [Phase 1]
Phase 1 clinical trial evaluating chemoembolization with embolization microspheres in adults with localized, non-resectable hepatocellular c…
-
CLINICAL_TRIALS research · 2016-08-19Clinical Trial Update: Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI [NA]
An exploratory clinical trial investigated tissue alterations in liver tumors induced by low-energy electromagnetic waves during MRI imaging…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating MM-141 in patients with advanced solid tumors has completed enrollment. Hepatocellular carcinoma is listed among th…
-
CLINICAL_TRIALS research · 2016-07-28Clinical Trial Update: Dynamic Contrast Enhanced HCC SABR Liver Study [NA]
Clinical trial update for a dynamic contrast-enhanced SABR liver study in hepatocellular carcinoma; the study status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation [Phase 1]
Phase 1 safety study evaluating NK cells derived from Sibship to treat recurrence of hepatocellular carcinoma after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating γδ T cell therapy for hepatocellular carcinoma has completed with reported safety and efficacy signals.
-
CLINICAL_TRIALS research · 2016-07-14Clinical Trial Update: In Vitro Models of Liver and Pancreatic Cancer
An update on a study using in vitro models to investigate liver cancers (cholangiocarcinoma and hepatocellular carcinoma) and pancreatic can…
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population. [NA]
This update describes a clinical trial evaluating a three-biomarker approach developed by WAKO to enable early diagnosis of hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of irreversible electroporation for refractory tumors in the liver…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
This clinical trial update notes termination of a Stanford-sponsored study evaluating C-arm CT during transarterial chemoembolization for he…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
A Stanford-led clinical trial investigating viral and host factors associated with HBV-related hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial
A randomized controlled trial evaluating follow-up strategies in chronic hepatitis B patients to enable earlier detection and diagnosis of h…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma [NA]
A completed clinical trial of microparticle enhanced cytotoxic transarterial embolization therapy for hepatocellular carcinoma has posted re…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position
A completed clinical trial evaluating a novel laparoscopic hepatectomy posture using left lateral and jackknife positions for hepatocellular…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Adjuvant TACE to Reduce the HCC Recurrence After Resection [Phase 3]
This document reports an update on a Phase 3 trial evaluating adjuvant transarterial chemoembolization (TACE) to reduce recurrence of hepato…
-
CLINICAL_TRIALS research · 2016-06-15Clinical Trial Update: The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluated the effects of Vitamin B-6 and Coenzyme Q10 status on oxidative stress, antioxidant cap…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma [Phase 2]
Phase 2 study of Prolarix in hepatocellular carcinoma was terminated; results posted in 2016.